Query: NC_013798:345339 Streptococcus gallolyticus UCN34, complete genome Lineage: Streptococcus gallolyticus; Streptococcus; Streptococcaceae; Lactobacillales; Firmicutes; Bacteria General Information: Isolated from a human case of endocarditis associated with colon cancer in Caen, France in 2001. Streptococci are non-motile, Gram-positive cocci with widely varying pathogenic potential that occur in pairs or chains. Streptococcus gallolyticus (strain UCN34, biotype I) is a commensal Gram-positive bacterium isolated from various habitats, including feces of many animals and from human clinical sources. S. gallolyticus is part of the rumen flora but also a cause of disease in ruminants as well as in birds (septicemia in pigeons, outbreaks in broiler flocks, or bovine mastitis). This is a tannin-degrading Streptococcus species. Strains have been isolated from various habitats, including feces of many animals and from human clinical sources. This organism can be a cause of infectious endocarditis.
- Sequence; - BLASTP hit: hover for score (Low score = Light, High score = Dark); - hypothetical protein; - cds: hover for description
General Information: Bacteria belonging to the Pseudomonas group are common inhabitants of soil and water and can also be found on the surfaces of plants and animals. Pseudomonas bacteria are found in nature in a biofilm or in planktonic form. Pseudomonas bacteria are renowned for their metabolic versatility as they can grow under a variety of growth conditions and do not need any organic growth factors. This organism is an opportunistic human pathogen. While it rarely infects healthy individuals, immunocompromised patients, like burn victims, AIDS-, cancer- or cystic fibrosis-patients are at increased risk for infection with this environmentally versatile bacteria. It is an important soil bacterium with a complex metabolism capable of degrading polycyclic aromatic hydrocarbons, and producing interesting, biologically active secondary metabolites including quinolones, rhamnolipids, lectins, hydrogen cyanide, and phenazines. Production of these products is likely controlled by complex regulatory networks making Pseudomonas aeruginosa adaptable both to free-living and pathogenic lifestyles. The bacterium is naturally resistant to many antibiotics and disinfectants, which makes it a difficult pathogen to treat.